Shopping Cart 0
Cart Subtotal
USD 0

University of Copenhagen - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

University of Copenhagen (UCPH) is a university and research institution that offers educational and research programs and services. The university' services include graduate and undergraduate courses, research programs, master's programs, continuing education services, online courses, international students courses, research databases, PhD programs and business collaborations courses. It also provides nanoscience and technology, chemical and biochemical engineering, applied cultural analysis, business administration and innovation in health care, environmental and natural resource economics, professional master programs, specialized and customized courses. UCPH's master's programs comprise master of companion animal clinical science, master of disaster management, master of headache disorders, master of industrial drug development, north sea energy law program and master of medicines regulatory affairs. The university provides its services through its departments and facilities. UCPH is headquartered in Copenhagen, Denmark.

University of Copenhagen-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Copenhagen, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Copenhagen, Medical Devices Deals, 2012 to YTD 2018 10

University of Copenhagen, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

University of Copenhagen, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

CiMaas Enters into Agreement with Cancer Research Technology and University of Copenhagen 12

Licensing Agreements 13

ADCendo Enters into Licensing Agreement with University of Copenhagen and Capital Region of Denmark 13

Equity Offering 14

Antag Therapeutics Spin Out from University of Copenhagen 14

University of Copenhagen-Key Competitors 15

University of Copenhagen-Key Employees 16

University of Copenhagen-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Recent Developments 19

Government and Public Interest 19

Oct 23, 2018: Research team receives new funding for continued research into the blood-brain barrier 19

Sep 20, 2018: Insulin Shows Great Potential Against Chronic Colitis 20

Aug 29, 2018: New strategic funding to metabolic research at the University of Copenhagen 21

Aug 17, 2018: Scientists create new technology and solve a key puzzle for cellular memory 23

Jul 25, 2018: New enzyme discovery may help improve drugs against cancer, diabetes and obesity 24

Jun 29, 2018: Enzyme may get key role in drug design for breast cancer and brain condition 25

May 14, 2018: Researchers uncover up to 100 potential drug targets for cancer 26

Apr 16, 2018: New Study Discovers Cancer-Relevant Protein Shield 28

Jan 23, 2018: Nordic collaboration receives 35 million DKK for personalised medicine 29

Dec 15, 2017: Distinct human mutations can alter the effect of medicine 30

Dec 14, 2017: Cellular Reprogramming fuels Wound Healing in the Intestine 31

Dec 14, 2017: New research linking cancer-inhibiting proteins to cell antennae 32

Nov 30, 2017: New Vaccine Technique Effectively Fights Breast Cancer in Mice 33

Nov 30, 2017: Oxygen Treatment Makes Antibiotics Work Again 34

Nov 08, 2017: Nanoshells could deliver more chemo with fewer side effects 35

Oct 31, 2017: University of Copenhagen: Researchers map trends in drug development 37

Sep 25, 2017: A new role for Insulin as a Vital Factor in Maintaining Stem Cells 38

Aug 24, 2017: New Ambitious Research Programme Receives DKK 100 million for Research into Leukaemia and New Treatment 39

Aug 23, 2017: Scientists discover common obesity and diabetes drug reduces rise in brain pressure 40

Jul 06, 2017: A New Molecular Scissors Act Like A GPS to Improve Genome Editing 41

May 17, 2017: Researchers take an important step toward an HIV vaccine 42

Apr 17, 2017: Novo Nordisk Foundation Grant 43

Mar 30, 2017: Eurostars funding for novel Zika vaccine 44

Feb 08, 2017: Oxygen under pressure increases effect of antimicrobial agents 45

Product News 46

Sep 26, 2018: New allergy vaccine for hay fever shows promising results 46

Mar 03, 2017: Bioneer: In the Forefront of Developing New Human Cell Models for Neurodegenerative Diseases 47

Jan 31, 2018: New technology: Edible QR code can be the medicine of the future 48

Other Significant Developments 49

Sep 26, 2018: Study: New allergy vaccine for hay fever shows promising results 49

Sep 12, 2018: Researchers uncover previously unstudied cancer enzyme 50

Sep 12, 2018: New method promises fewer side-effects from cancer drugs 51

Jun 18, 2018: Study Examines First Birth Cohort to Receive HPV Vaccine: The Vaccine Works 52

May 30, 2018: Study Offers New Hope for the Fight Against Genetically Determined Obesity 54

Appendix 56

Methodology 56

About GlobalData 56

Contact Us 56

Disclaimer 56


List Of Figure

List of Figures

University of Copenhagen, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Copenhagen, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

University of Copenhagen, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

University of Copenhagen, Pharmaceuticals & Healthcare, Key Facts 2

University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

University of Copenhagen, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

University of Copenhagen, Deals By Therapy Area, 2012 to YTD 2018 9

University of Copenhagen, Medical Devices Deals, 2012 to YTD 2018 10

University of Copenhagen, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

CiMaas Enters into Agreement with Cancer Research Technology and University of Copenhagen 12

ADCendo Enters into Licensing Agreement with University of Copenhagen and Capital Region of Denmark 13

Antag Therapeutics Spin Out from University of Copenhagen 14

University of Copenhagen, Key Competitors 15

University of Copenhagen, Key Employees 16

University of Copenhagen, Subsidiaries 17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

University of Copenhagen, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.